BioCentriq Appoints Syed T. Husain as Chief Executive Officer
BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), announces that it has appointed Syed T. Husain as its new Chief Executive Officer (CEO), and as a member of the Board of Directors. BioCentriq has selected Syed for his extensive expertise in CDMO development and manufact…
